Disruption of Four-and-a-Half LIM 2 Decreases Bone Mineral Content and Bone Mineral Density in Femur and Tibia Bones of Female Mice
Authors:
- 15 August 2006
- journal article
- research article
- Published by Springer Nature in Calcified Tissue International
- Vol. 79 (2) , 112-117
Abstract
Four-and-a-half LIM 2 (FHL2) is a member of a family of LIM domain proteins which mediate protein-protein interactions. FHL2 acts as a coactivator and binds to important regulators of bone formation such as insulin-like growth factor binding protein (IGFBP)-5, androgen receptor, and β-catenin. We hypothesized that FHL2 is an important regulator of bone formation. We evaluated growth and skeletal parameters in FHL2 knockout (KO) and wild-type (WT) mice at 4, 8, and 12 weeks of age. At 4 weeks of age, lack of FHL2 reduced femur, tibia, and total bone mineral content (BMC) and body weight in all mice. A gender-by-treatment interaction (P ≤ 0.05) was observed for several parameters due to a greater reduction in females. Specifically, femur BMC was reduced 11–27% at 8 and 12 weeks of age and BMD was reduced 7–13% at all ages in female KO mice (P < 0.05). A similar reduction was observed in the tibias at 8 weeks of age. A 6% reduction (P = 0.07) in femur cortical thickness was observed at 12 weeks of age in female KO mice. Interestingly, a gender-specific reduction in IGFBP-5 expression was observed in the femurs of female KO mice. During differentiation of bone marrow stromal cells into osteoblasts, expression of osteocalcin, alkaline phosphatase, and bone sialoprotein was reduced 47–96% in FHL2 KO cells (P < 0.001). In conclusion, FHL2 is an important regulator of peak bone mass, lack of FHL2 produces gender- and site-specific effects on bone accretion and IGFBP-5 expression, and FHL2 is important for optimal osteoblast differentiation in vitro.Keywords
This publication has 39 references indexed in Scilit:
- Four and Half Lim Protein 2 (FHL2) Stimulates Osteoblast DifferentiationJournal of Bone and Mineral Research, 2006
- Interaction and Functional Cooperation between the LIM Protein FHL2, CBP/p300, and β-CateninMolecular and Cellular Biology, 2004
- The multi-functional role of insulin-like growth factor binding proteins in bonePediatric Nephrology, 2004
- Extracellular Signal-Regulated Kinase 2 Interacts with and Is Negatively Regulated by the LIM-Only Protein FHL2 in CardiomyocytesMolecular and Cellular Biology, 2004
- Identification of the LIM Protein FHL2 as a Coactivator of β-CateninJournal of Biological Chemistry, 2003
- Tests of Linkage and/or Association of Genes for Vitamin D Receptor, Osteocalcin, and Parathyroid Hormone With Bone Mineral DensityJournal of Bone and Mineral Research, 2002
- Generation of a New Congenic Mouse Strain to Test the Relationships Among Serum Insulin-like Growth Factor I, Bone Mineral Density, and Skeletal Morphology In VivoJournal of Bone and Mineral Research, 2002
- Quantitative Trait Loci for Femoral and Lumbar Vertebral Bone Mineral Density in C57BL/6J and C3H/HeJ Inbred Strains of MiceJournal of Bone and Mineral Research, 2001
- Expression of insulin-like growth factor binding proteins by T-47D human breast cancer cells: regulation by progestins and antiestrogensBreast Cancer Research and Treatment, 1994
- Regulation of insulin-like growth factor binding proteins in ovarian cancer cells by oestrogenEuropean Journal of Cancer, 1993